Harvard Bioscience, Inc.
HBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,231 | -$2,282 | -$50,340 | $18 |
| Dep. & Amort. | $1,324 | $1,616 | $1,655 | $1,760 |
| Deferred Tax | $20 | -$50 | $0 | $724 |
| Stock-Based Comp. | $0 | $472 | $600 | $961 |
| Change in WC | $290 | $2,789 | $3,512 | -$593 |
| Other Non-Cash | $427 | $210 | $47,559 | -$1,145 |
| Operating Cash Flow | $830 | $2,755 | $2,986 | $1,725 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$348 | -$89 | -$513 | -$301 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$144 | -$170 | -$165 |
| Investing Cash Flow | -$348 | -$233 | -$683 | -$466 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,000 | -$1,000 | -$1,000 | -$1,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$75 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$24 | -$258 | -$129 | -$357 |
| Financing Cash Flow | -$1,024 | -$1,258 | -$1,204 | -$1,357 |
| Forex Effect | -$83 | $632 | $339 | -$363 |
| Net Chg. in Cash | -$625 | $1,896 | $1,438 | -$461 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,442 | $5,546 | $4,108 | $4,569 |
| End Cash | $6,817 | $7,442 | $5,546 | $4,108 |
| Free Cash Flow | $623 | $2,522 | $2,473 | $1,259 |